Canada: cannabis stocks swell and threaten to drive down prices
If the first year of Canadian legalization was marked by a shortage of, the trend seems to be reversing. Canada is now facing a cannabis surplus that threatens to drive prices down, while the fledgling industry is still struggling to make a profit.
Strong, steady growth in inventories of unfinished products
Health Canada defines unfinished inventory as «all dried cannabis in inventory held by a licensed grower or processor that is not packaged and ready for sale». According to Health Canada data, This stock (in light green) is growing much faster than sales (in violet):
Between the start of legalization and August 2019, the inventory of unfinished products more than tripled, and has been growing exponentially since March. August 2019 finished goods inventory is already 5 times sales for the month. Total inventory represents 30 times sales. If sales were to stagnate at 13,000 kilograms a month, this stock could supply the market for over 2 years.
However, unfinished stock also includes manicure waste such as leaves and stems. What's more, despite slow growth, sales have been rising steadily since March 2019. They will therefore absorb part of the potential surplus.
A race to the bottom?
For some time now, the major Canadian producers have been working to expand their production areas in order to produce more at lower cost and offer more competitive prices. Aurora Cannabis, whose production capacity currently stands at 150,000 kilos/year, plans to expand to 500,000 kilos/year by 2020. This capacity will match that of Canopy Growth, also on track to reach 500,000 kilos/year.
«There's a lot of capacity and a lot of funding to add more, so this will inevitably lead to a moment of supply balance, then oversupply.», explains Tom Adams, BDS analyst. However, if the combined production capacity of producers exceeds the absorption capacity of the legal consumer market by too much, the surplus generated will lead to a fall in prices. This is the law of supply and demand.
For Matt Bottomley, I think there will be a race to the bottom in terms of prices, because now everyone has enough stock«. Some producers have already begun to lower their prices: Hexo Corp has just offered a new line of products (Original Stash) at 4.49$, i.e. 50% below the average price per gram on the legal market.
If prices fall too much, producers will sell at a loss. So it's in their interest not to produce too much. Hexo Corp, for example, has announced the closure of one of its greenhouses and the suspension of its expansion project. Another option is to sell the surplus on wholesale markets to avoid a drop in consumer prices. According to Forbes analyst Stephen McBride, Aurora practices this form of dumping.
«When we look at Aurora's most recent financial reports, we see that its revenues increased by 52% in the last fiscal quarter compared to the previous one. But this hides a dirty secret. The company has dumpé the equivalent of $20 million worth of cannabis, representing an increase of 869% compared to the previous fiscal quarter. The reason she's doing this is because there's not enough demand from consumers».
For Matt Bottomley, on the other hand, supply is not so much out of step with growing demand. «I don't think there's a surplus of cannabis in inventory that the demand from the illicit cannabis market can't absorb,» he explains. «I think the problem is that our distribution infrastructure and online product offering aren't developed enough to be able to attract people who come through the illegal channels.».
-
Cannabis in Africa3 days ago
Nigeria moves a step closer to legalizing medical cannabis
-
Cannabis in France5 days ago
Le Champ d’en Face aims to bring hemp back into the public discourse
-
Business4 weeks ago
Will CBD edibles be banned on May 15 in France? An update on the situation
-
Cannabis in France5 days ago
French CBD industry to challenge CBD product control plan in court
-
Cannabis in the Caribbean5 days ago
Antigua and Barbuda: When Cannabis Becomes a Cultural Destination and a Tool for Sovereignty
-
Cannabinoids5 days ago
Japan bans CBN
-
Cannabis in the U.S.4 days ago
Trump's reclassification of cannabis is being challenged in court
-
Business3 days ago
Germany imported over 50 tonnes of medical cannabis in the first quarter of 2026



You must be logged in to post a comment Login